Yoichiro Tanaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yoichiro Tanaka has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Taiichi Sakamoto
Chiba Institute of Technology
11 shared publications - Yasuyuki Kurihara
Laboratory of Molecular Biology, Graduate School of Engineering, Yokohama National University, Tokiwadai, Hodogaya-ku, Yokohama 240-8501, Japan
10 shared publications Masato Katahira
Institute of Advanced Energy Kyoto University Uji Japan
7 shared publicationsTomoko Kozu
Research Institute for Clinical Oncology Saitama Cancer CenterIna Japan
7 shared publicationsYoshikazu Nakamura
Department of Basic Medical Sciences Institute of Medical Science University of Tokyo Minato‐ku Japan
7 shared publicationsGota Kawai
Department of Life and Environmental Sciences, Faculty of Engineering, Chiba Institute of Technology , 2-17-1 Tsudanuma, Narashino, Chiba 275-0016, Japan
4 shared publications
Latest Publications
- 4 February 2026
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 141 (5) , 391-397
Dual-color membrane-type immunoglobulin-directed hybridoma screening for selective and accelerated monoclonal antibody production
- 4 February 2026
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 141 (5) , 391-397
Dual-color membrane-type immunoglobulin-directed hybridoma screening for selective and accelerated monoclonal antibody production
- Open Access
- 1 October 2025
- Published by Elsevier in Mitochondrion
- Vol. 86, 102082
COXFA4L3 enhances mitochondrial complex IV function to boost ATP synthesis and drive sperm motility
- 1 October 2025
- Published by Elsevier in Mitochondrion
- Vol. 86, 102082
Open AccessCOXFA4L3 enhances mitochondrial complex IV function to boost ATP synthesis and drive sperm motility
- Open Access
Induced Radionuclides and Their Activity Concentration in Gel Dosimeters Irradiated by Carbon Ion Beam
Radioactivity was measured in a micellar gel dosimeter, a polymer gel dosimeter, and water was irradiated by carbon ion beams at various beam energy conditions. Monte Carlo simulation was also performed to estimate the radioactivity. Short-lived positron-emitting nuclides were observed immediately after irradiation, but they decayed rapidly into the background. At 24 h post-irradiation, the dominant measured radioactivity was of 7Be. The simulation also showed minor activity of 24Na and 3H; however, they were not experimentally observed. The measured radioactivity was independent of the type of gel dosimeter under all irradiation conditions, suggesting that the radioactivity was induced by the interaction of carbon ions with water (the main component of the gel dosimeters). The ratio between the simulated and measured radioactivity was within 0.9–1.5. The activity concentration of 7Be was found to be less than 1/10 of the value derived using the exemption concept proposed by the International Atomic Energy Agency. This result should be applicable to irradiated gel dosimeters containing mainly water and 0–4 wt.% C and 0–1.7 wt.% N.
Open AccessInduced Radionuclides and Their Activity Concentration in Gel Dosimeters Irradiated by Carbon Ion Beam
Radioactivity was measured in a micellar gel dosimeter, a polymer gel dosimeter, and water was irradiated by carbon ion beams at various beam energy conditions. Monte Carlo simulation was also performed to estimate the radioactivity. Short-lived positron-emitting nuclides were observed immediately after irradiation, but they decayed rapidly into the background. At 24 h post-irradiation, the dominant measured radioactivity was of 7Be. The simulation also showed minor activity of 24Na and 3H; however, they were not experimentally observed. The measured radioactivity was independent of the type of gel dosimeter under all irradiation conditions, suggesting that the radioactivity was induced by the interaction of carbon ions with water (the main component of the gel dosimeters). The ratio between the simulated and measured radioactivity was within 0.9–1.5. The activity concentration of 7Be was found to be less than 1/10 of the value derived using the exemption concept proposed by the International Atomic Energy Agency. This result should be applicable to irradiated gel dosimeters containing mainly water and 0–4 wt.% C and 0–1.7 wt.% N.
- 11 September 2020
- Published by Wiley in FEBS Letters
- Vol. 594 (21) , 3477-3489
A G‐quadruplex‐forming RNA aptamer binds to the MTG8 TAFH domain and dissociates the leukemic AML1‐MTG8 fusion protein from DNA
MTG8 (RUNX1T1) is a fusion partner of AML1 (RUNX1) in the leukemic chromosome translocation t(8;21). The AML1‐MTG8 fusion gene encodes a chimeric transcription factor. One of the highly conserved domains of MTG8 is TAFH which possesses homology with human TAF4 [TATA‐box binding protein‐associated factor]. To obtain specific inhibitors of the AML1‐MTG8 fusion protein, we isolated RNA aptamers against the MTG8 TAFH domain using systematic evolution of ligands by exponential enrichment. All TAF aptamers contained guanine‐rich sequences. Analyses of a TAF aptamer by NMR, CD, and mutagenesis revealed that it forms a parallel G‐quadruplex structure in the presence of K+. Furthermore, the aptamer could bind to the AML1‐MTG8 fusion protein and dissociate the AML1‐MTG8/DNA complex, suggesting that it can inhibit the dominant negative effects of AML1‐MTG8 against normal AML1 function and serve as a potential therapeutic agent for leukemia.
- 11 September 2020
- Published by Wiley in FEBS Letters
- Vol. 594 (21) , 3477-3489
A G‐quadruplex‐forming RNA aptamer binds to the MTG8 TAFH domain and dissociates the leukemic AML1‐MTG8 fusion protein from DNA
MTG8 (RUNX1T1) is a fusion partner of AML1 (RUNX1) in the leukemic chromosome translocation t(8;21). The AML1‐MTG8 fusion gene encodes a chimeric transcription factor. One of the highly conserved domains of MTG8 is TAFH which possesses homology with human TAF4 [TATA‐box binding protein‐associated factor]. To obtain specific inhibitors of the AML1‐MTG8 fusion protein, we isolated RNA aptamers against the MTG8 TAFH domain using systematic evolution of ligands by exponential enrichment. All TAF aptamers contained guanine‐rich sequences. Analyses of a TAF aptamer by NMR, CD, and mutagenesis revealed that it forms a parallel G‐quadruplex structure in the presence of K+. Furthermore, the aptamer could bind to the AML1‐MTG8 fusion protein and dissociate the AML1‐MTG8/DNA complex, suggesting that it can inhibit the dominant negative effects of AML1‐MTG8 against normal AML1 function and serve as a potential therapeutic agent for leukemia.
- 1 April 2018
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 125 (4) , 464-469
Flow cytometry-based method for rapid and high-throughput screening of hybridoma cells secreting monoclonal antibody
- 1 April 2018
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 125 (4) , 464-469
Flow cytometry-based method for rapid and high-throughput screening of hybridoma cells secreting monoclonal antibody
- Open Access
- 2 January 2018
- Published by Wiley in FEBS Open Bio
- Vol. 8 (2) , 264-270
Characterisation of an aptamer against the Runt domain of AML1 (RUNX1) by NMR and mutational analyses
Since the invention of SELEX (Systematic Evolution of Ligands by Exponential Enrichment), many short oligonucleotides (or aptamers) have been reported that can bind to a wide range of target molecules with high affinity and specificity. Previously, we reported an RNA aptamer that shows high affinity to the Runt domain of the AML1 protein, a transcription factor with roles in haematopoiesis and immune function. From kinetic and thermodynamic studies, it was suggested that the aptamer recognises a large surface area of the Runt domain, using numerous weak interactions. In this study, we identified the secondary structure by NMR spectroscopy and performed a mutational study to reveal the residue critical for binding to the Runt domain. It was suggested that the large contact area was formed by a DNA-mimicking motif and a multi-branched loop, which confers the high affinity and specificity of binding.
- 2 January 2018
- Published by Wiley in FEBS Open Bio
- Vol. 8 (2) , 264-270
Open AccessCharacterisation of an aptamer against the Runt domain of AML1 (RUNX1) by NMR and mutational analyses
Since the invention of SELEX (Systematic Evolution of Ligands by Exponential Enrichment), many short oligonucleotides (or aptamers) have been reported that can bind to a wide range of target molecules with high affinity and specificity. Previously, we reported an RNA aptamer that shows high affinity to the Runt domain of the AML1 protein, a transcription factor with roles in haematopoiesis and immune function. From kinetic and thermodynamic studies, it was suggested that the aptamer recognises a large surface area of the Runt domain, using numerous weak interactions. In this study, we identified the secondary structure by NMR spectroscopy and performed a mutational study to reveal the residue critical for binding to the Runt domain. It was suggested that the large contact area was formed by a DNA-mimicking motif and a multi-branched loop, which confers the high affinity and specificity of binding.
- Open Access
- 14 July 2017
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 162 (6) , 431-436
Conjugation of two RNA aptamers improves binding affinity to AML1 Runt domain
To develop a high-affinity aptamer against AML1 Runt domain, two aptamers were conjugated based on their structural information. The newly designed aptamer Apt14 was generated by the conjugation of two RNA aptamers (Apt1 and Apt4) obtained by SELEX against AML1 Runt domain, resulting in improvement in its binding performance. The residues of AML1 Runt domain in contact with Apt14 were predicted in silico and confirmed by mutation and NMR analyses. It was suggested that the conjugated internal loop renders additional contacts and is responsible for the enhancement in the binding affinity. Conjugation of two aptamers that bind to different sites of the target protein is a facile and robust strategy to develop an aptamer with higher performance.
- 14 July 2017
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 162 (6) , 431-436
Open AccessConjugation of two RNA aptamers improves binding affinity to AML1 Runt domain
To develop a high-affinity aptamer against AML1 Runt domain, two aptamers were conjugated based on their structural information. The newly designed aptamer Apt14 was generated by the conjugation of two RNA aptamers (Apt1 and Apt4) obtained by SELEX against AML1 Runt domain, resulting in improvement in its binding performance. The residues of AML1 Runt domain in contact with Apt14 were predicted in silico and confirmed by mutation and NMR analyses. It was suggested that the conjugated internal loop renders additional contacts and is responsible for the enhancement in the binding affinity. Conjugation of two aptamers that bind to different sites of the target protein is a facile and robust strategy to develop an aptamer with higher performance.
- 1 November 2016
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 55 (45) , 6221-6229
Kinetic and Thermodynamic Analyses of Interaction between a High-Affinity RNA Aptamer and Its Target Protein
AML1 (RUNX1) protein is an essential transcription factor involved in the development of hematopoietic cells. Several genetic aberrations that disrupt the function of AML1 have been frequently observed in human leukemia. AML1 contains a DNA-binding domain known as the Runt domain (RD), which recognizes the RD-binding double-stranded DNA element of target genes. In this study, we identified high-affinity RNA aptamers that bind to RD by systematic evolution of ligands by exponential enrichment. The binding assay using surface plasmon resonance indicated that a shortened aptamer retained the ability to bind to RD when 1 M potassium acetate was used. A thermodynamic study using isothermal titration calorimetry (ITC) showed that the aptamer–RD interaction is driven by a large enthalpy change, and its unfavorable entropy change is compensated by a favorable enthalpy change. Furthermore, the binding heat capacity change was identified from the ITC data at various temperatures. The aptamer binding showed a large negative heat capacity change, which suggests that a large apolar surface is buried upon such binding. Thus, we proposed that the aptamer binds to RD with long-range electrostatic force in the early stage of the association and then changes its conformation and recognizes a large surface area of RD. These findings about the biophysics of aptamer binding should be useful for understanding the mechanism of RNA–protein interaction and optimizing and modifying RNA aptamers.
- 1 November 2016
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 55 (45) , 6221-6229
Kinetic and Thermodynamic Analyses of Interaction between a High-Affinity RNA Aptamer and Its Target Protein
AML1 (RUNX1) protein is an essential transcription factor involved in the development of hematopoietic cells. Several genetic aberrations that disrupt the function of AML1 have been frequently observed in human leukemia. AML1 contains a DNA-binding domain known as the Runt domain (RD), which recognizes the RD-binding double-stranded DNA element of target genes. In this study, we identified high-affinity RNA aptamers that bind to RD by systematic evolution of ligands by exponential enrichment. The binding assay using surface plasmon resonance indicated that a shortened aptamer retained the ability to bind to RD when 1 M potassium acetate was used. A thermodynamic study using isothermal titration calorimetry (ITC) showed that the aptamer–RD interaction is driven by a large enthalpy change, and its unfavorable entropy change is compensated by a favorable enthalpy change. Furthermore, the binding heat capacity change was identified from the ITC data at various temperatures. The aptamer binding showed a large negative heat capacity change, which suggests that a large apolar surface is buried upon such binding. Thus, we proposed that the aptamer binds to RD with long-range electrostatic force in the early stage of the association and then changes its conformation and recognizes a large surface area of RD. These findings about the biophysics of aptamer binding should be useful for understanding the mechanism of RNA–protein interaction and optimizing and modifying RNA aptamers.
- 1 February 2016
- Published by Elsevier in Journal of Environmental Radioactivity
- Vol. 152, 28-34
Radiocesium immobilization to leaf litter by fungi during first-year decomposition in a deciduous forest in Fukushima
- 1 February 2016
- Published by Elsevier in Journal of Environmental Radioactivity
- Vol. 152, 28-34
Radiocesium immobilization to leaf litter by fungi during first-year decomposition in a deciduous forest in Fukushima
- Open Access
- 1 January 2016
- Published by Scitechnol Biosoft Pvt. Ltd. in Journal of Clinical & Experimental Nephrology
- Vol. 01 (01)
Polymyxin B hemoperfusion improves hemodynamic status in patients with sepsis with both gram-negative and nongram- negative bacteria
Background: Direct hemoperfusion with a polymyxin B (PMX) often produces improvement in patients with sepsis caused by bacteria other than those classified as gram-negative. The aim of the present study is to clarify the therapeutic effects of PMX in patients with sepsis caused by bacteria other than gram-negative bacteria. Methods and Findings: We enrolled 41 patients with severe sepsis including various other diseases, which were treated with PMX. We evaluated the improvement in blood pressure, vasopressor requirement, respiratory condition, Sequential Organ Failure Assessment (SOFA), inotropic score, and serum biochemical markers before and after PMX therapy. PMX therapy improved inotropic scores (14.3 to 8.4, p?0.01) and small decrease partial SOFA scores (2.8 to 2.1, p?0.01). We compared hemodynamic scores between patients with gram-negative bacteria (GN group) and non-gram-negative bacteria (non-GN group). Changes in blood pressure, inotropic score and partial SOFA scores by PMX therapy showed no significant differences between the GN and non-GN groups (p = 0.26, p = 0.11 and p = 0.3, respectively). Furthermore, we compared the 28-day mortality between GN and non-GN groups. As a result, there is no significant deference. (p = 0.85). Conclusion: PMX therapy is effective to improve hemodynamic status of septic patients not only with gram-negative but with non-gram-negative bacteria. Main limitation is that the sample size was relatively small and the study was performed in a single center.
- 1 January 2016
- Published by Scitechnol Biosoft Pvt. Ltd. in Journal of Clinical & Experimental Nephrology
- Vol. 01 (01)
Open AccessPolymyxin B hemoperfusion improves hemodynamic status in patients with sepsis with both gram-negative and nongram- negative bacteria
Background: Direct hemoperfusion with a polymyxin B (PMX) often produces improvement in patients with sepsis caused by bacteria other than those classified as gram-negative. The aim of the present study is to clarify the therapeutic effects of PMX in patients with sepsis caused by bacteria other than gram-negative bacteria. Methods and Findings: We enrolled 41 patients with severe sepsis including various other diseases, which were treated with PMX. We evaluated the improvement in blood pressure, vasopressor requirement, respiratory condition, Sequential Organ Failure Assessment (SOFA), inotropic score, and serum biochemical markers before and after PMX therapy. PMX therapy improved inotropic scores (14.3 to 8.4, p?0.01) and small decrease partial SOFA scores (2.8 to 2.1, p?0.01). We compared hemodynamic scores between patients with gram-negative bacteria (GN group) and non-gram-negative bacteria (non-GN group). Changes in blood pressure, inotropic score and partial SOFA scores by PMX therapy showed no significant differences between the GN and non-GN groups (p = 0.26, p = 0.11 and p = 0.3, respectively). Furthermore, we compared the 28-day mortality between GN and non-GN groups. As a result, there is no significant deference. (p = 0.85). Conclusion: PMX therapy is effective to improve hemodynamic status of septic patients not only with gram-negative but with non-gram-negative bacteria. Main limitation is that the sample size was relatively small and the study was performed in a single center.